Clinical Trial Update: Access Protocol for MAB-425 Radiolabeled With I-125 for High Grade Gliomas [NA]

View source ↗

Summary

An access protocol update for a trial using MAB-425 radiolabeled with I-125 to treat high-grade gliomas, with the trial status listed as unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anaplastic Astrocytoma
• Glioblastoma

Drugs mentioned

• MAB-425 radiolabeled with I-125 (MAB-425)

Snippet

Sponsor: Drexel University | Conditions: Glioblastoma Multiforme, Astrocytoma Anaplastic Foci | NA | Status: UNKNOWN